Researchers are testing a new approach using an amphiphilic cancer vaccine to deliver CAR T-cell therapy to solid tumors, and the results of preclinical studies are promising, according to findings published in the journal Science.
On September 17, 2019, the U.S. Food and Drug Administration (FDA) granted accelerated approval to the combination of pembrolizumab (Keytruda®) plus lenvatinib (Lenvima®) for the treatment of patients with advanced endometrial carcinoma that is not microsatellite instability high (MSI-H) or mismatch repair deficient (dMMR) and who have disease progression following prior systemic therapy but are not candidates for curative surgery or radiation.
How are you taking care of yourself? It’s a question I’ve asked many team members, including leaders I have had the privilege of serving, over the course of my career. I’ve even added this question into certain candidate interviews to assess resiliency in individuals. And of course I ask it of myself often. That’s because it is my professional responsibility to ensure I am caring for myself. Provision 5 of the Code of Ethics for Nurses says, “The nurse owes the same duties to self as to others, including the responsibility to promote health and safety.”
When my son was in nursery school, his teachers encouraged him to express his frustration with others by “using his words” rather than lashing out in some other nonproductive way. I was reminded of the power of words delivered by a compelling speaker when watching a video of the comedian and advocate, Jon Stewart, testifying before the U.S. House of Representatives Judiciary Committee about the needs of 9/11 first responders. His passion was evident in his voice, in his emotionally laden pauses, and in the words that he used to describe the ongoing healthcare concerns of those heroes.
Oncology nursing-led research is the engine that drives practice change when caring for patients with cancer. As a standard-bearer of oncology nursing research and a veteran of nursing research publications, Debra Lyon, RN, PhD, FNP-BC, FAAN, will bring a wealth of expertise and experience to the Oncology Nursing Forum (ONF), becoming the research journal’s sixth editor effective January 1, 2020.
With more deaths reported from vaping and a forceful U.S. Senate declaration to the U.S. Food and Drug Administration (FDA) acting commissioner to either enact stronger federal provisions restricting e-cigarettes, flavored tobacco, and inhalants or resign, the Trump administration moved quickly to demonstrate a recognition that cessation is a national, bipartisan concern.
Palbociclib (Ibrance), ribociclib (Kisqali), and abemaciclib (Verzenio) used to treat some patients with advanced breast cancers may cause rare but severe inflammation of the lungs, the U.S. Food and Drug Administration (FDA) announced on September 13, 2019. It approved new warnings about the risk on the prescribing information and package insert for the entire class of cyclin-dependent kinase 4/6 (CDK 4/6) inhibitor medicines. However, “the overall benefit of CDK 4/6 inhibitors is still greater than the risks when used as prescribed,” the agency noted.
Personal development is a lifelong process. It’s a way to assess our skills and qualities, consider our aims in life, and set goals to realize and maximize our potential. Part of personal development involves challenging ourselves to learn and master new skills. The more we put ourselves out there—away from our comfort zone to try new things—the more we learn about ourselves.
Patients with hematologic cancers have a 19% increased risk for blood clots or bleeding events even 10 years after diagnosis, according to the results of a study published in the Journal of Thrombosis and Haemostasis.
Bags used to store and administer total parenteral nutrition (TPN) are being recalled because of leaks near the divider rod and channel when the rod is removed, the Metrix Company of Dubuque, IA, announced on September 9, 2019.